这是一篇来自已证抗体库的有关人类 CYP3A4的综述,是根据19篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CYP3A4 抗体。
CYP3A4 同义词: CP33; CP34; CYP3A; CYP3A3; CYPIIIA3; CYPIIIA4; HLP; NF-25; P450C3; P450PCN1; cytochrome P450 3A4; 1,8-cineole 2-exo-monooxygenase; P450-III, steroid inducible; albendazole monooxygenase; albendazole sulfoxidase; cholesterol 25-hydroxylase; cytochrome P450 3A3; cytochrome P450 HLp; cytochrome P450 NF-25; cytochrome P450, family 3, subfamily A, polypeptide 4; cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 3; cytochrome P450, subfamily IIIA (niphedipine oxidase), polypeptide 4; cytochrome P450-PCN1; glucocorticoid-inducible P450; nifedipine oxidase; quinine 3-monooxygenase; taurochenodeoxycholate 6-alpha-hydroxylase

圣克鲁斯生物技术
小鼠 单克隆
  • 免疫印迹; 人类; 图 3d
圣克鲁斯生物技术 CYP3A4抗体(Santa, HL3)被用于被用于免疫印迹在人类样品上 (图 3d). Carcinogenesis (2017) ncbi
小鼠 单克隆(HL3)
  • 免疫印迹; 人类; 图 3d
圣克鲁斯生物技术 CYP3A4抗体(Santa, HL3)被用于被用于免疫印迹在人类样品上 (图 3d). Carcinogenesis (2017) ncbi
小鼠 单克隆(P6)
  • 免疫印迹; 小鼠; 1:500; 图 10a
圣克鲁斯生物技术 CYP3A4抗体(SantaCruz, sc-53246)被用于被用于免疫印迹在小鼠样品上浓度为1:500 (图 10a). Drug Metab Dispos (2017) ncbi
小鼠 单克隆(HL3)
  • 免疫印迹; 人类; 图 6c
圣克鲁斯生物技术 CYP3A4抗体(Santa Cruz, sc-53850)被用于被用于免疫印迹在人类样品上 (图 6c). Sci Rep (2016) ncbi
小鼠 单克隆(HL3)
  • 免疫印迹; 人类; 图 6b
圣克鲁斯生物技术 CYP3A4抗体(Santa Cruz, sc-53850)被用于被用于免疫印迹在人类样品上 (图 6b). Toxicol Lett (2016) ncbi
小鼠 单克隆(HL3)
  • 免疫印迹; 人类; 图 6
圣克鲁斯生物技术 CYP3A4抗体(Santa Cruz, sc-53850)被用于被用于免疫印迹在人类样品上 (图 6). Nat Commun (2016) ncbi
小鼠 单克隆(P6)
  • 免疫印迹; 大鼠; 1:500
圣克鲁斯生物技术 CYP3A4抗体(Santa Cruz, sc-53246)被用于被用于免疫印迹在大鼠样品上浓度为1:500. Toxicol In Vitro (2015) ncbi
小鼠 单克隆(HL3)
  • 免疫印迹; 人类; 1:2000
圣克鲁斯生物技术 CYP3A4抗体(Santa Cruz Biotechnology, sc-53850)被用于被用于免疫印迹在人类样品上浓度为1:2000. Arch Toxicol (2014) ncbi
亚诺法生技股份有限公司
兔 多克隆
  • 酶联免疫吸附测定; 人类
亚诺法生技股份有限公司 CYP3A4抗体(Abnova, H00001576-D01P)被用于被用于酶联免疫吸附测定在人类样品上. Basic Clin Pharmacol Toxicol (2015) ncbi
兔 多克隆
  • 免疫沉淀; 人类
  • 免疫印迹; 人类
亚诺法生技股份有限公司 CYP3A4抗体(Abnova, H00001576-D01)被用于被用于免疫沉淀在人类样品上 和 被用于免疫印迹在人类样品上. Pharmacol Res Perspect (2014) ncbi
伯乐(Bio-Rad)公司
兔 多克隆
  • 免疫组化; 人类
伯乐(Bio-Rad)公司 CYP3A4抗体(AbD Serotec, AHP622Z)被用于被用于免疫组化在人类样品上. PLoS ONE (2015) ncbi
艾博抗(上海)贸易有限公司
兔 多克隆
  • 免疫细胞化学; 人类; 1:50; 图 6e
艾博抗(上海)贸易有限公司 CYP3A4抗体(Abcam, ab135813)被用于被用于免疫细胞化学在人类样品上浓度为1:50 (图 6e). Stem Cell Res (2016) ncbi
赛默飞世尔
兔 多克隆
  • 免疫印迹; 人类; 图 1g
赛默飞世尔 CYP3A4抗体(ThermoFisher, PA1-343)被用于被用于免疫印迹在人类样品上 (图 1g). Toxicol In Vitro (2017) ncbi
默克密理博中国
兔 多克隆
  • 免疫细胞化学; 人类; 1:500; 图 2e
默克密理博中国 CYP3A4抗体(Millipore, AB1254)被用于被用于免疫细胞化学在人类样品上浓度为1:500 (图 2e). Sci Rep (2017) ncbi
小鼠 单克隆
  • 免疫印迹; 人类
默克密理博中国 CYP3A4抗体(Millipore, MAB10041)被用于被用于免疫印迹在人类样品上. Biochem Pharmacol (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:2000; 图 1c
默克密理博中国 CYP3A4抗体(Millipore, AB1254)被用于被用于免疫印迹在人类样品上浓度为1:2000 (图 1c). PLoS ONE (2014) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 2
默克密理博中国 CYP3A4抗体(Millipore, AB1254)被用于被用于免疫印迹在人类样品上 (图 2). Mol Biol Rep (2013) ncbi
兔 多克隆
  • 免疫组化; 人类; 1:200
默克密理博中国 CYP3A4抗体(Millipore, AB1254)被用于被用于免疫组化在人类样品上浓度为1:200. Pain (2013) ncbi
兔 多克隆
  • 免疫印迹; 人类
默克密理博中国 CYP3A4抗体(Millipore, AB1254)被用于被用于免疫印迹在人类样品上. PLoS Negl Trop Dis (2012) ncbi
兔 多克隆
  • 免疫印迹; 人类
默克密理博中国 CYP3A4抗体(Chemicon, AB1254)被用于被用于免疫印迹在人类样品上. Biotechnol Bioeng (2013) ncbi
文章列表
  1. Valanejad L, Lewis K, Wright M, Jiang Y, D Souza A, Karns R, et al. FXR-Gankyrin axis is involved in development of pediatric liver cancer. Carcinogenesis. 2017;38:738-747 pubmed 出版商
  2. Cheng S, Bammler T, Cui J. RNA Sequencing Reveals Age and Species Differences of Constitutive Androstane Receptor-Targeted Drug-Processing Genes in the Liver. Drug Metab Dispos. 2017;45:867-882 pubmed 出版商
  3. Gamal W, Treskes P, Samuel K, Sullivan G, Siller R, Srsen V, et al. Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liver. Sci Rep. 2017;7:37541 pubmed 出版商
  4. Vogel K, Ainslie G, Roullet J, McConnell A, Gibson K. In vitro toxicological evaluation of NCS-382, a high-affinity antagonist of ?-hydroxybutyrate (GHB) binding. Toxicol In Vitro. 2017;40:196-202 pubmed 出版商
  5. Milkiewicz M, Klak M, Kempińska Podhorodecka A, Wiechowska Kozlowska A, Urasinska E, Blatkiewicz M, et al. Impaired Hepatic Adaptation to Chronic Cholestasis induced by Primary Sclerosing Cholangitis. Sci Rep. 2016;6:39573 pubmed 出版商
  6. Štěpánková M, Krasulová K, Doricakova A, Kurka O, Anzenbacher P, Dvorak Z. Optical isomers of dihydropyridine calcium channel blockers display enantiospecific effects on the expression and enzyme activities of human xenobiotics-metabolizing cytochromes P450. Toxicol Lett. 2016;262:173-186 pubmed 出版商
  7. Carpentier A, Nimgaonkar I, Chu V, Xia Y, Hu Z, Liang T. Hepatic differentiation of human pluripotent stem cells in miniaturized format suitable for high-throughput screen. Stem Cell Res. 2016;16:640-50 pubmed 出版商
  8. Kabe Y, Nakane T, Koike I, Yamamoto T, Sugiura Y, Harada E, et al. Haem-dependent dimerization of PGRMC1/Sigma-2 receptor facilitates cancer proliferation and chemoresistance. Nat Commun. 2016;7:11030 pubmed 出版商
  9. Wang Y, Chai S, Lin W, Chai X, Elias A, Wu J, et al. Serine 350 of human pregnane X receptor is crucial for its heterodimerization with retinoid X receptor alpha and transactivation of target genes in vitro and in vivo. Biochem Pharmacol. 2015;96:357-68 pubmed 出版商
  10. Van Peer E, De Bock L, Boussery K, Van Bocxlaer J, Casteleyn C, Van Ginneken C, et al. Age-related Differences in CYP3A Abundance and Activity in the Liver of the Göttingen Minipig. Basic Clin Pharmacol Toxicol. 2015;117:350-7 pubmed 出版商
  11. Vichi S, Sandström von Tobel J, Gemma S, Stanzel S, Kopp Schneider A, Monnet Tschudi F, et al. Cell type-specific expression and localization of cytochrome P450 isoforms in tridimensional aggregating rat brain cell cultures. Toxicol In Vitro. 2015;30:176-84 pubmed 出版商
  12. Strick Marchand H, Dusséaux M, Darche S, Huntington N, Legrand N, Masse Ranson G, et al. A novel mouse model for stable engraftment of a human immune system and human hepatocytes. PLoS ONE. 2015;10:e0119820 pubmed 出版商
  13. Fujiwara R, Itoh T. Extensive protein interactions involving cytochrome P450 3A4: a possible contributor to the formation of a metabolosome. Pharmacol Res Perspect. 2014;2:e00053 pubmed 出版商
  14. Smutny T, Bitman M, Urban M, Dubecka M, Vrzal R, Dvorak Z, et al. U0126, a mitogen-activated protein kinase kinase 1 and 2 (MEK1 and 2) inhibitor, selectively up-regulates main isoforms of CYP3A subfamily via a pregnane X receptor (PXR) in HepG2 cells. Arch Toxicol. 2014;88:2243-59 pubmed 出版商
  15. Chen F, Rao X, Yang J, Pan M, Gao Y, Li Z, et al. Up-regulating CYP3A4 expression in C3A cells by transfection with a novel chimeric regulator of hPXR-p53-AD. PLoS ONE. 2014;9:e95752 pubmed 出版商
  16. Li W, Zhong S, Wu Y, Xu W, Xu J, Tang J, et al. Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines. Mol Biol Rep. 2013;40:6143-50 pubmed
  17. Ruparel S, Hargreaves K, Eskander M, Rowan S, de Almeida J, Roman L, et al. Oxidized linoleic acid metabolite-cytochrome P450 system (OLAM-CYP) is active in biopsy samples from patients with inflammatory dental pain. Pain. 2013;154:2363-71 pubmed 出版商
  18. Rigalli J, Perdomo V, Luquita M, Villanueva S, Arias A, Theile D, et al. Regulation of biotransformation systems and ABC transporters by benznidazole in HepG2 cells: involvement of pregnane X-receptor. PLoS Negl Trop Dis. 2012;6:e1951 pubmed 出版商
  19. Yang Y, Li J, Pan X, Zhou P, Yu X, Cao H, et al. Co-culture with mesenchymal stem cells enhances metabolic functions of liver cells in bioartificial liver system. Biotechnol Bioeng. 2013;110:958-68 pubmed 出版商